logo
Select company
Select metric
-291.58%EBIT Margin
VS
Market
9
Sector
30
Industry
53
History
67
$ 9.84Close
$ 8.24 - $ 28.14 52-Week Range
Ticker Information

Ticker

NRIX

Company Name

NURIX THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

NURIX THERAPEUTICS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NRIX - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
9/30/2025$ -244.02M-291.58%$ 83.69M
6/30/2025$ -206.47M-233.61%$ 88.38M
3/31/2025$ -208.22M-369.08%$ 56.42M
12/31/2024$ -193.3M-354.36%$ 54.55M
9/30/2024$ -176.71M-313.19%$ 56.42M
6/30/2024$ -164.82M-264.55%$ 62.3M
3/31/2024$ -144.64M-178.82%$ 80.89M
12/31/2023$ -143.95M-186.98%$ 76.99M
9/30/2023$ -148.71M-216.74%$ 68.61M
6/30/2023$ -157.44M-258.37%$ 60.94M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NURIX THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT % stands at -357.9%.
  • Over the past 5 years, NURIX THERAPEUTICS INC's average EBIT % has been -330.21%.
  • The median EBIT % for NURIX THERAPEUTICS INC during this period was -354.36%
  • NURIX THERAPEUTICS INC reached its highest EBIT % over the past 5 years at -178.82%.
  • The lowest EBIT % recorded by NURIX THERAPEUTICS INC in the same timeframe -466.93%

NURIX THERAPEUTICS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
SNDX : SYNDAX PHARMACEUTICALS INC -401.96%URGN : UROGEN PHARMA LTD -144.32%TBPH : THERAVANCE BIOPHARMA INC 55.25%KURA : KURA ONCOLOGY INC -232.16%GYRE : GYRE THERAPEUTICS INC 6.85%ZVRA : ZEVRA THERAPEUTICS INC 48.18%CRMD : CORMEDIX INC 42.57%NAGE : NIAGEN BIOSCIENCE INC 15.76%SAGE : SAGE THERAPEUTICS INC -427.77%EYPT : EYEPOINT PHARMACEUTICALS INC -337.55%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for NURIX THERAPEUTICS INC is calculated as follows: EBIT [ $ -63.78M ] / Revenues [ $ 17.82M ]
(=) EBIT % [ -357.9% ]

NRIX - EBIT Margin, Last 5 years

-466.93%

Minimum

Dec 31, 2022

-178.82%

Maximum

Mar 31, 2024

-330.21%

Average

-354.36%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.54% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.54%
median9.01%
std23.96%